NCT07179055View on ClinicalTrials.gov

An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

PHASE2RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Dry Eye
Interventions
DRUG

VSJ-110

ophthalmic solution

DRUG

Placebo

ophthalmic solution

Trial Locations (5)

24502

NOT_YET_RECRUITING

Vanda Investigational Site, Lynchburg

28150

NOT_YET_RECRUITING

Vanda Investigational Site, Shelby

38119

RECRUITING

Vanda Investigational Site, Memphis

92663

RECRUITING

Vanda Investigational Site, Newport Beach

01810

NOT_YET_RECRUITING

Vanda Investigational Site, Andover

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY